CVE-2015-3957

CVE-2015-3957 is a medium-severity vulnerability in Hospira Lifecare Pcainfusion Firmware with a CVSS 2.0 base score of 4.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-255.

Key facts

Description

Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.

Frequently asked questions

What is CVE-2015-3957?
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.
How severe is CVE-2015-3957?
CVE-2015-3957 has a CVSS 2.0 base score of 4.6, rated medium severity.
Is CVE-2015-3957 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-3957?
CVE-2015-3957 primarily affects Hospira Lifecare Pcainfusion Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2015-3957?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2015-3957 published?
CVE-2015-3957 was published on 2015-07-06 and last updated on 2026-06-17.

References

Affected products (3)

More vulnerabilities in Hospira Lifecare Pcainfusion Firmware

All CVEs affecting Hospira Lifecare Pcainfusion Firmware →

Other CWE-255 (Credentials Management Errors) vulnerabilities

Browse all CWE-255 (Credentials Management Errors) vulnerabilities →